1.
Vitamin D and Cardiovascular Disease
by Wang, Thomas J
Annual review of medicine, 2016, Vol.67 (1), p.261-272
2.
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
by Mahmood, Syed S, MD
The Lancet (British edition), 2014, Vol.383 (9921), p.999-1008
3.
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes
by Bachmann, Katherine N
Diabetologia, 2017, Vol.61 (5), p.987-995
4.
Metabolite profiles and the risk of developing diabetes
by Wang, Thomas J
Nature medicine, 2011, Vol.17 (4), p.448-453
5.
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
by Schnabel, Renate B, MD
The Lancet (British edition), 2009, Vol.373 (9665), p.739-745
6.
The search for new cardiovascular biomarkers
by Gerszten, Robert E
Nature, 2008, Vol.451 (7181), p.949-952
7.
Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose
by Merino, Jordi
Diabetologia, 2018, Vol.61 (6), p.1315-1324
8.
Left Ventricular Hypertrophy Patterns and Incidence of Heart Failure With Preserved Versus Reduced Ejection Fraction
by Velagaleti, Raghava S., MD
The American journal of cardiology, 2014, Vol.113 (1), p.117-122
9.
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
by Mayers, Jared R
Nature medicine, 2014, Vol.20 (10), p.1193-1198
10.
Reference Limits for N-Terminal-pro-B-Type Natriuretic Peptide in Healthy Individuals (from the Framingham Heart Study)
by Fradley, Michael G., MD
The American journal of cardiology, 2011, Vol.108 (9), p.1341-1345
11.
Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation
by Schnabel, Renate B., MD, MSc
The American journal of cardiology, 2009, Vol.104 (1), p.92-96
12.
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis)
by Gupta, Deepak K
The American journal of cardiology, 2017, Vol.120 (6), p.1008-1015
13.
Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmö Diet and Cancer Study
by Magnusson, Martin
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (2), p.638-645
14.
Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease
by Khan, Abigail May, MD
The American heart journal, 2010, Vol.160 (4), p.715-720
15.
Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation
by Rienstra, Michiel, MD, PhD
The American heart journal, 2014, Vol.167 (1), p.109-115.e2
16.
Cardiac Natriuretic Peptides, Obesity, and Insulin Resistance: Evidence from Two Community-Based Studies
by Khan, Abigail May
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (10), p.3242-3249
17.
Exercise Blood Pressure and the Risk of Incident Cardiovascular Disease (from the Framingham Heart Study)
by Lewis, Gregory D., MD
The American journal of cardiology, 2008, Vol.101 (11), p.1614-1620
18.
Vitamin D status is not related to development of atrial fibrillation in the community
by Rienstra, Michiel, MD, PhD
The American heart journal, 2011, Vol.162 (3), p.538-541
19.
Vitamin D Supplementation Modulates T Cell–Mediated Immunity in Humans: Results from a Randomized Control Trial
by Konijeti, Gauree Gupta
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (2), p.533-538
20.
Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (From the Framingham Heart Study)
by Ko, Darae, MD
The American journal of cardiology, 2016, Vol.118 (10), p.1493-1496
